RT Journal Article
T1 Open questions and misconceptions in the diagnosis and management of anemia in patients with gastrointestinal bleeding.
T2 Preguntas y errores en el diagnóstico y manejo de la anemia en pacientes con hemorragia digestiva.
A1 Mearin, Fermín
A1 Lanas, Ángel
A1 Bujanda, Luis
A1 Canelles, Pilar
A1 Cotter, José
A1 Hervás, Antonio
A1 Martín de Argila, Carlos
A1 Montoro, Miguel
A1 Gisbert, Javier P
K1 Anemia
K1 Diagnosis
K1 Diagnóstico
K1 Gastrointestinal bleeding
K1 Hemorragia digestiva
K1 Hierro
K1 Iron
K1 Tratamientos
K1 Treatments
AB Despite high prevalence of iron deficiency anemia (IDA) in patients with acute or chronic gastrointestinal bleeding (GIB), IDA and iron deficiency (ID) are frequently untreated. Reasons may be misconceptions about the impact and diagnosis of IDA and the efficacy of new treatments. Addressing these misconceptions, this article summarizes current evidence for better understanding and management of GIB-associated IDA. Despite only few controlled studies evaluated the efficacy of iron treatment in patients with GIB, there is consistent evidence suggesting that: (a) IDA should be diligently investigated, (b) effective treatment of ID/IDA improves outcomes such as health-related quality of life and can avoid severe cardiovascular consequences, and (c) intravenous iron should be considered as well-tolerated treatment in this setting. Overall, the misconceptions and practices outlined in this article should be replaced with strategies that are more in line with current guidelines and best practice in GIB and other underlying conditions of ID/IDA.
SN 0210-5705
YR 2017
FD 2017-10-27
LK http://hdl.handle.net/10668/11771
UL http://hdl.handle.net/10668/11771
LA en
LA es
DS RISalud
RD Apr 9, 2025